{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:00:35Z","timestamp":1790431235191,"version":"4.1.0"},"reference-count":218,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The term \u2018differences of sex development\u2019 (DSD) refers to a group of congenital conditions that are associated with atypical development of chromosomal, gonadal, or anatomical sex. Disorders of steroidogenesis comprise autosomal recessive conditions that affect adrenal and gonadal enzymes and are responsible for some conditions of 46,XX DSD where hyperandrogenism interferes with chromosomal and gonadal sex development. Congenital adrenal hyperplasias (CAHs) are disorders of steroidogenesis that mainly involve the adrenals (21-hydroxylase and 11-hydroxylase deficiencies) and sometimes the gonads (3-beta-hydroxysteroidodehydrogenase and P450-oxidoreductase); in contrast, aromatase deficiency mainly involves the steroidogenetic activity of the gonads. This review describes the main genetic, biochemical, and clinical features that apply to the abovementioned conditions. The activities of the steroidogenetic enzymes are modulated by post-translational modifications and cofactors, particularly electron-donating redox partners. The incidences of the rare forms of CAH vary with ethnicity and geography. The elucidation of the precise roles of these enzymes and cofactors has been significantly facilitated by the identification of the genetic bases of rare disorders of steroidogenesis. Understanding steroidogenesis is important to our comprehension of differences in sexual development and other processes that are related to human reproduction and fertility, particularly those that involve androgen excess as consequence of their impairment.<\/jats:p>","DOI":"10.3390\/ijms20184605","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T10:42:58Z","timestamp":1568716978000},"page":"4605","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["46,XX DSD due to Androgen Excess in Monogenic Disorders of Steroidogenesis: Genetic, Biochemical, and Clinical Features"],"prefix":"10.3390","volume":"20","author":[{"given":"Federico","family":"Baronio","sequence":"first","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ortolano","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soara","family":"Menab\u00f2","sequence":"additional","affiliation":[{"name":"Genetic Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cassio","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Baldazzi","sequence":"additional","affiliation":[{"name":"Genetic Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Di Natale","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Tonti","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Vestrucci","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Balsamo","sequence":"additional","affiliation":[{"name":"Pediatric Unit, Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/adc.2006.098319","article-title":"LWPES Consensus Group; ESPE Consensus Group. Consensus statement on management of intersex disorders","volume":"91","author":"Hughes","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"ref_2","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000488034","article-title":"Monogenic Disorders of Adrenal Steroidogenesis","volume":"89","author":"Baranowski","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_4","first-page":"102","article-title":"A proposed nosology of inborn errors of metabolism","volume":"21","author":"Ferreira","year":"2019","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-18-0279","article-title":"Mechanisms in endocrinology: Rare defects in adrenal steroidogenesis","volume":"179","author":"Miller","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12020-018-01835-3","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 3\u03b2-hydroxysteroid dehydrogenase type 2 deficiency","volume":"63","author":"Falhammar","year":"2019","journal-title":"Endocrine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ng0792-239","article-title":"Congenital adrenal hyperplasia due to point mutations in the type II 3 beta-hydroxysteroid dehydrogenase gene","volume":"1","author":"Simard","year":"1992","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI107977","article-title":"Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia","volume":"55","author":"Schneider","year":"1975","journal-title":"J. Clin. Investig."},{"key":"ref_10","first-page":"450","article-title":"Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency","volume":"76","author":"Barnes","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","first-page":"1968","article-title":"A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty","volume":"85","author":"Alos","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","first-page":"1012","article-title":"Molecular basis of congenital adrenal hyperplasia in two siblings with classical nonsalt-losing 3 beta-hydroxysteroid dehydrogenase deficiency","volume":"79","author":"Sanchez","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","first-page":"4410","article-title":"New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes","volume":"84","author":"Moisan","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","first-page":"948","article-title":"A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3\u03b2-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts","volume":"52","author":"Huang","year":"2014","journal-title":"Zhonghua Er Ke Za Zhi Chin. J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1210\/jc.2015-2098","article-title":"Severe Salt-Losing 3\u03b2-Hydroxysteroid Dehydrogenase Deficiency: Treatment and Outcomes of HSD3B2 c.35G>A Homozygotes","volume":"100","author":"Benkert","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1677\/jme.0.0120119","article-title":"Mutation in 3 beta-hydroxysteroid dehydrogenase type II associated with pseudohermaphroditism in males and premature pubarche or cryptic expression in females","volume":"12","author":"Russell","year":"1994","journal-title":"J. Mol. Endocrinol."},{"key":"ref_17","first-page":"204","article-title":"A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis","volume":"68","author":"Forest","year":"2007","journal-title":"Horm. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/jcem-56-4-808","article-title":"Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function","volume":"56","author":"Pang","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","first-page":"1251","article-title":"Hypothalamic-pituitary-gonadal axis function in pubertal male and female siblings with glucocorticoid-treated nonsalt-wasting 3 beta-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia","volume":"77","author":"Chang","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","first-page":"200","article-title":"Non-Virilizing Congenital Adrenal Hyperplasia in a Female Patient with a Novel HSD3B2 Mutation","volume":"10","author":"Udhane","year":"2016","journal-title":"Sex. Dev. Genet. Mol. Biol. Evol. Endocrinol. Embryol. Pathol. Sex Determ. Differ."},{"key":"ref_21","first-page":"2556","article-title":"A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia","volume":"87","author":"Pang","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1677\/jme.0.0120225","article-title":"Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss","volume":"12","author":"Russell","year":"1994","journal-title":"J. Mol. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2004-1374","article-title":"Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency","volume":"90","author":"Johannsen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/cen.12394","article-title":"Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for \u03945-steroids","volume":"80","author":"Takasawa","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/hmg\/4.4.745","article-title":"A novel missense mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene in a family with classical salt-wasting congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency","volume":"4","author":"Katsumata","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1210\/jc.2014-2676","article-title":"A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3\u03b2-hydroxysteroid dehidrogenase type II","volume":"100","author":"Baquedano","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jcem-51-2-345","article-title":"Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency","volume":"51","author":"Rosenfield","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","first-page":"561","article-title":"Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency","volume":"78","author":"Sanchez","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_30","first-page":"1149","article-title":"Hyperandrogenism due to 3 beta-hydroxysteroid dehydrogenase deficiency with accessory adrenocortical tissue: a hormonal and metabolic evaluation","volume":"27","author":"Paula","year":"1994","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0015-0282(00)00668-3","article-title":"Genotyping of the type II 3beta-hydroxysteroid dehydrogenase gene (HSD3B2) in women with hirsutism and elevated ACTH-stimulated delta(5)-steroids","volume":"74","author":"Marui","year":"2000","journal-title":"Fertil. Steril."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2265.2000.00873.x","article-title":"Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls","volume":"52","author":"Marui","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/4.5.969","article-title":"Molecular analysis of type II 3 beta-hydroxysteroid dehydrogenase gene in Japanese patients with classical 3 beta-hydroxysteroid dehydrogenase deficiency","volume":"4","author":"Tajima","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","first-page":"291","article-title":"A new compound heterozygous frameshift mutation in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene causes salt-wasting 3 beta-HSD deficiency congenital adrenal hyperplasia","volume":"81","author":"Zhang","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","first-page":"82","article-title":"Two Moroccan Sisters Presenting with a Severe Salt-Wasting Form of Congenital Adrenal Hyperplasia but Normal Female Genitalia","volume":"11","author":"Scaramuzzo","year":"2017","journal-title":"Sex. Dev. Genet. Mol. Biol. Evol. Endocrinol. Embryol. Pathol. Sex Determ. Differ."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000336004","article-title":"A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3\u03b2-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency","volume":"77","author":"Jeandron","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mce.2017.08.022","article-title":"Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population","volume":"461","author":"Alswailem","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ando.2014.03.002","article-title":"Steroidogenesis of the testis\u2014New genes and pathways","volume":"75","author":"Pandey","year":"2014","journal-title":"Ann. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1074\/jbc.272.12.7899","article-title":"Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome p450scc and 3beta-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells","volume":"272","author":"Cherradi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/MCB.01107-15","article-title":"An Outer Mitochondrial Translocase, Tom22, Is Crucial for Inner Mitochondrial Steroidogenic Regulation in Adrenal and Gonadal Tissues","volume":"36","author":"Rajapaksha","year":"2016","journal-title":"Mol. Cell. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jc.2004-1552","article-title":"Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping","volume":"90","author":"Mermejo","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2002-0050","article-title":"Molecular biology of the 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase gene family","volume":"26","author":"Simard","year":"2005","journal-title":"Endocr. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","article-title":"Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"121","author":"Krone","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2265.2003.01716.x","article-title":"Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test","volume":"58","author":"Pang","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_46","first-page":"2611","article-title":"Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency","volume":"87","author":"Lutfallah","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1172\/JCI104666","article-title":"The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase","volume":"41","author":"Bongiovanni","year":"1962","journal-title":"J. Clin. Investig."},{"key":"ref_48","first-page":"bcr2015213939","article-title":"High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia","volume":"2016","year":"2016","journal-title":"BMJ Case Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1590\/0004-2730000003098","article-title":"3\u03b2-hydroxysteroid dehydrogenase type II deficiency on newborn screening test","volume":"58","author":"Gameleira","year":"2014","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tem.2017.09.002","article-title":"Steroidogenesis: Unanswered Questions","volume":"28","author":"Miller","year":"2017","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000481660","article-title":"Adrenal Crises in Children: Perspectives and Research Directions","volume":"89","author":"Rushworth","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","article-title":"Genetics of congenital adrenal hyperplasia","volume":"23","author":"Krone","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_54","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (2016, February 04). 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1171\/."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"365","author":"Merke","year":"2005","journal-title":"Lancet Lond. Engl."},{"key":"ref_56","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1073\/pnas.83.12.4243","article-title":"Structure of a bovine gene for P-450c21 (steroid 21-hydroxylase) defines a novel cytochrome P-450 gene family","volume":"83","author":"Chung","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.83.9.2841","article-title":"Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene","volume":"83","author":"Higashi","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/humu.23351","article-title":"CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants","volume":"39","author":"Simonetti","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_60","first-page":"233","article-title":"Impact of molecular genetics on congenital adrenal hyperplasia management","volume":"4","author":"Balsamo","year":"2010","journal-title":"Sex. Dev. Genet. Mol. Biol. Evol. Endocrinol. Embryol. Pathol. Sex Determ. Differ."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20916","DOI":"10.1016\/S0021-9258(17)45304-X","article-title":"Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus","volume":"265","author":"Traktman","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2265.2000.01048.x","article-title":"CYP21 analysis and phenotype\/genotype relationship in the screened population of the Italian Emilia-Romagna region","volume":"53","author":"Balsamo","year":"2000","journal-title":"Clin. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/EC-18-0281","article-title":"Genotype\/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients","volume":"8","author":"Riedl","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/jc.2002-021681","article-title":"CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","first-page":"1145","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation","volume":"78","author":"Wedell","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_69","first-page":"3293","article-title":"Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population","volume":"82","author":"Levo","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000481911","article-title":"Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome","volume":"89","author":"Miller","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa002939","article-title":"A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency","volume":"345","author":"Schalkwijk","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/376564","article-title":"Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome","volume":"73","author":"Zweers","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1210\/jc.2012-3148","article-title":"Tenascin-X Haploinsufficiency Associated with Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia","volume":"98","author":"Merke","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","article-title":"Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia","volume":"100","author":"Morissette","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jmoldx.2019.06.001","article-title":"High-Throughput Screening for CYP21A1P-TNXA\/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia","volume":"21","author":"Lao","year":"2019","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0997-104","article-title":"Tenascin-X deficiency is associated with Ehlers-Danlos syndrome","volume":"17","author":"Burch","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/humu.23028","article-title":"Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia","volume":"37","author":"Chen","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jsbmb.2013.04.010","article-title":"11\u03b2-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5\u03b1-reductase yielding 11\u03b2-hydroxy-5\u03b1-androstanedione","volume":"138","author":"Swart","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy, P.J., Antignac, J.P., Le Bizec, B., Morvan, M.-L., Svechnikov, K., S\u00f6der, O., Savchuk, I., Monteiro, A., Soffientini, U., and Johnston, Z.C. (2019). Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000002"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.06.009","article-title":"Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation","volume":"89","author":"Pandey","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \u201cbackdoor\u201d pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1196\/annals.1429.021","article-title":"Congenital adrenal hyperplasia in adolescents: diagnosis and management","volume":"1135","author":"Nimkarn","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI25091","article-title":"In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development","volume":"116","author":"Goto","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1210\/jc.2016-2311","article-title":"11-Ketotestosterone Is a Major Androgen Produced in Human Gonads","volume":"101","author":"Imamichi","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","first-page":"4589","article-title":"11-Ketotestosterone Is the Dominant Circulating Bioactive Androgen During Normal and Premature Adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2017.12.016","article-title":"Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia","volume":"178","author":"Kamrath","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Bacila, I., Adaway, J., Hawley, J., Mahdi, S., Krone, R., Patel, L., Alvi, S., Randell, T., Gevers, E., and Dattani, M. (2019). Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab.","DOI":"10.1210\/jc.2019-00031"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM200011093431903","article-title":"Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency","volume":"343","author":"Merke","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpeds.2005.04.035","article-title":"Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls","volume":"147","author":"Varness","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2002-012093","article-title":"High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland","volume":"87","author":"Steigert","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_93","first-page":"362","article-title":"Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980\u20131995","volume":"98","author":"Balsamo","year":"1996","journal-title":"Pediatrics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2003-032235","article-title":"Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia","volume":"89","author":"Minutti","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1210\/jc.2006-2890","article-title":"Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry","volume":"92","author":"Janzen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet Lond. Engl."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E1022","DOI":"10.1210\/jc.2014-1118","article-title":"Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma","volume":"99","author":"New","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/2230-8210.111596","article-title":"Prenatal treatment of mothers with fetuses at risk for congenital adrenal hyperplasia: How relevant is it to Indian context?","volume":"17","author":"Eunice","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fertnstert.2018.11.041","article-title":"Prenatal genetic testing and treatment for congenital adrenal hyperplasia","volume":"111","author":"Simpson","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10897-012-9508-8","article-title":"Prenatal treatment of congenital adrenal hyperplasia-not standard of care","volume":"21","author":"Witchel","year":"2012","journal-title":"J. Genet. Couns."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1210\/jcem.86.12.8072","article-title":"Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies","volume":"86","author":"New","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"U63","DOI":"10.1530\/eje.0.151u063","article-title":"Prenatal treatment of congenital adrenal hyperplasia","volume":"151","author":"Lajic","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2012-1222","article-title":"Prenatal Dexamethasone Treatment of Children at Risk for Congenital Adrenal Hyperplasia: The Swedish Experience and Standpoint","volume":"97","author":"Hirvikoski","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2016-1543","article-title":"Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone","volume":"101","author":"Wallensteen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1210\/jc.2006-1340","article-title":"Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone","volume":"92","author":"Hirvikoski","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/cen.13441","article-title":"Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia","volume":"87","author":"Karlsson","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/js.2018-00377","article-title":"Epigenetic Alterations Associated With Early Prenatal Dexamethasone Treatment","volume":"3","author":"Karlsson","year":"2019","journal-title":"J. Endocrine Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"Arlt","year":"2017","journal-title":"Lancet Lond. Engl."},{"key":"ref_110","first-page":"48","article-title":"Should CAH in Females Be Classified as DSD?","volume":"4","author":"Ludwikowski","year":"2016","journal-title":"Front. Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.juro.2011.10.162","article-title":"Surgical treatment of high urogenital sinuses using the anterior sagittal transrectal approach: a useful strategy to optimize exposure and outcomes","volume":"187","author":"Salle","year":"2012","journal-title":"J. Urol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fped.2013.00041","article-title":"The Surgical Correction of Urogenital Sinus in Patients with DSD: 15 Years after Description of Total Urogenital Mobilization in Children","volume":"1","author":"Ludwikowski","year":"2013","journal-title":"Front. Pediatr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-8587(13)70138-4","article-title":"Management of adolescents with congenital adrenal hyperplasia","volume":"1","author":"Merke","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jpurol.2013.03.013","article-title":"Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey","volume":"9","author":"Yankovic","year":"2013","journal-title":"J. Pediatr. Urol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.juro.2015.06.104","article-title":"Characterizing Early Psychosocial Functioning of Parents of Children with Moderate to Severe Genital Ambiguity due to Disorders of Sex Development","volume":"194","author":"Suorsa","year":"2015","journal-title":"J. Urol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1210\/jc.2018-01863","article-title":"Genital Reconstructive Surgery in Females With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis","volume":"103","author":"Almasri","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpurol.2018.10.008","article-title":"Variations of sex development: The first German interdisciplinary consensus paper","volume":"15","author":"Krege","year":"2019","journal-title":"J. Pediatr. Urol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/EJE-16-0888","article-title":"Management of endocrine disease: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment","volume":"176","author":"Bachelot","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsbmb.2016.03.021","article-title":"Surgical outcomes and complications of reconstructive surgery in the female congenital adrenal hyperplasia patient: What every endocrinologist should know","volume":"165","author":"Wang","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1210\/jc.2013-3326","article-title":"Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden","volume":"99","author":"Strandqvist","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_122","first-page":"3535","article-title":"A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia","volume":"81","author":"Laue","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem.85.3.6462","article-title":"Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia","volume":"85","author":"Merke","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2265.2009.03636.x","article-title":"A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia","volume":"72","author":"Verma","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/17446651.2018.1455496","article-title":"Immediate-release granule formulation of hydrocortisone, Alkindi\u00ae, for treatment of paediatric adrenal insufficiency (Infacort development programme)","volume":"13","author":"Porter","year":"2018","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000281417","article-title":"Three novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11Beta-hydroxylase deficiency in a moroccan population","volume":"74","author":"Chabraoui","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-56-2-222","article-title":"Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients","volume":"56","author":"Zachmann","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.90.10.4552","article-title":"Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8","volume":"90","author":"Curnow","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","first-page":"2896","article-title":"CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency","volume":"81","author":"Geley","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","first-page":"270","article-title":"Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency","volume":"83","author":"Merke","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_131","first-page":"37","article-title":"Clinical, Hormonal and Molecular Genetic Characterization of Hungarian Patients with 11\u03b2-Hydroxylase Deficiency","volume":"2","author":"Solyom","year":"2011","journal-title":"Int. J. Disabil. Hum. Dev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1515\/JPEM.2005.18.2.133","article-title":"Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency","volume":"18","author":"Motaghedi","year":"2005","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1210\/jc.2005-0089","article-title":"Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene","volume":"90","author":"Krone","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tem.2008.01.002","article-title":"Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia","volume":"19","author":"Nimkarn","year":"2008","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1210\/jc.2008-2521","article-title":"Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients","volume":"94","author":"Soardi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2009-0651","article-title":"Functional consequences of seven novel mutations in the CYP11B1 gene: Four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency","volume":"95","author":"Parajes","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00431-009-1110-1","article-title":"Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS+4A to G) in one CYP11B1 allele and R448H in exon 8 in the other","volume":"169","author":"Dumic","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygcen.2011.12.017","article-title":"Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11\u03b2 hydroxylase deficiency in a Tunisian family","volume":"175","author":"Riepe","year":"2012","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsbmb.2012.08.011","article-title":"A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency","volume":"133","author":"Zhang","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_140","first-page":"e191","article-title":"Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation","volume":"20","author":"Qasem","year":"2014","journal-title":"Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Dumic, K., Yuen, T., Grubic, Z., Kusec, V., Barisic, I., and New, M.I. (2014). Two Novel CYP11B1 Gene Mutations in Patients from Two Croatian Families with 11\u03b2-Hydroxylase Deficiency. Int. J. Endocrinol., 2014.","DOI":"10.1155\/2014\/185974"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ejhg.2013.197","article-title":"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations","volume":"22","author":"Polat","year":"2014","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Charnwichai, P., Yeetong, P., Suphapeetiporn, K., Supornsilchai, V., Sahakitrungruang, T., and Shotelersuk, V. (2016). Splicing analysis of CYP11B1 mutation in a family affected with 11\u03b2-hydroxylase deficiency: case report. BMC Endocr. Disord., 16.","DOI":"10.1186\/s12902-016-0118-6"},{"key":"ref_144","first-page":"172","article-title":"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: description of a new mutation, R384X","volume":"47","year":"2016","journal-title":"Colomb. M\u00e9d."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2016.03.006","article-title":"Novel and prevalent CYP11B1 gene mutations in Turkish patients with 11-\u03b2 hydroxylase deficiency","volume":"165","author":"Kandemir","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","article-title":"Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"114","author":"Khattab","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13048-018-0450-8","article-title":"Non-classical 11\u03b2-hydroxylase deficiency caused by compound heterozygous mutations: a case study and literature review","volume":"11","author":"Wang","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2018.04.001","article-title":"Prevalence, clinical characteristics and long-term outcomes of classical 11 \u03b2-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene","volume":"181","author":"Toksoy","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/jpem-2018-0298","article-title":"Typical characteristics of children with congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency: a single-centre experience and review of the literature","volume":"32","author":"Breil","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12020-018-1691-4","article-title":"Insights on the phenotypic heterogenity of 11\u03b2-hydroxylase deficiency: clinical and genetic studies in two novel families","volume":"62","author":"Valadares","year":"2018","journal-title":"Endocrine"},{"key":"ref_151","first-page":"4445","article-title":"Unequal crossing-over between aldosterone synthase and 11beta-hydroxylase genes causes congenital adrenal hyperplasia","volume":"86","author":"Hampf","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40618-015-0362-z","article-title":"Improving the diagnosis of 11\u03b2-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2\/CYP11B1 gene in a Sicilian patient","volume":"39","author":"Boccassini","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.65.4.777","article-title":"Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia","volume":"65","author":"Holcombe","year":"1980","journal-title":"Pediatrics"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/6.11.1829","article-title":"CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency","volume":"6","author":"Joehrer","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_155","first-page":"189","article-title":"Cosegregation of a novel homozygous CYP11B1 mutation with the phenotype of non-classical congenital adrenal hyperplasia in a consanguineous family","volume":"67","author":"Peters","year":"2007","journal-title":"Horm. Res."},{"key":"ref_156","first-page":"e12537","article-title":"Gender Identity in Patients with Congenital Adrenal Hyperplasia","volume":"15","author":"Karimi","year":"2017","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_157","first-page":"294","article-title":"Successful pregnancy in a patient with severe 11-beta-hydroxylase deficiency and novel mutations in CYP11B1 gene","volume":"68","author":"Simm","year":"2007","journal-title":"Horm. Res."},{"key":"ref_158","first-page":"321","article-title":"Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence","volume":"72","author":"Belgorosky","year":"2009","journal-title":"Horm. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-72-3-560","article-title":"A new cause of female pseudohermaphroditism: placental aromatase deficiency","volume":"72","author":"Shozu","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_160","first-page":"666","article-title":"Genetic studies to characterize the origin of the mutation in placental aromatase deficiency","volume":"51","author":"Harada","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"ref_161","first-page":"1287","article-title":"A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)","volume":"78","author":"Conte","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1073\/pnas.90.24.11673","article-title":"Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries","volume":"90","author":"Ito","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_164","first-page":"4","article-title":"Female pseudohermaphroditism (FPH) resulting from aromatase (P450arom) deficiency associated with a novel mutation (R457X) in the CYP19 gene","volume":"46\/S2","author":"Forest","year":"1996","journal-title":"Hormone Res."},{"key":"ref_165","first-page":"1739","article-title":"Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood","volume":"82","author":"Mullis","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1515\/JPEM.1998.11.5.657","article-title":"Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene","volume":"11","author":"Ludwig","year":"1998","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1210\/jc.2003-030433","article-title":"Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene","volume":"88","author":"Belgorosky","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2265.2007.02948.x","article-title":"The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues","volume":"67","author":"Pepe","year":"2007","journal-title":"Clin. Endocrinol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1210\/jc.2006-1181","article-title":"Variable phenotypes associated with aromatase (CYP19) insufficiency in humans","volume":"92","author":"Lin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_170","unstructured":"Richter-Unruh, A., Schmidt, M., Verhoef-Post, M., and Themmen, A. (2008, January 15\u201318). Aromatase deficiency: delayed puberty in a German girl is due to 2 new mutations of the CYP19 gene. Proceedings of the ENDO 2008: The Endocrine Society 90th Annual Meeting, San Francisco, CA, USA."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.2011.04012.x","article-title":"Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the CYP19A1 gene","volume":"75","author":"Schoenle","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2014.03.008","article-title":"Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies","volume":"390","author":"Bouchoucha","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Gagliardi, L., Scott, H.S., Feng, J., and Torpy, D.J. (2014). A case of Aromatase deficiency due to a novel CYP19A1 mutation. BMC Endocr. Disord., 14.","DOI":"10.1186\/1472-6823-14-16"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1210\/jc.2014-2967","article-title":"Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect","volume":"100","author":"Marino","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000437142","article-title":"An Intron 9 CYP19 Gene Variant (IVS9+5G>A), Present in an Aromatase-Deficient Girl, Affects Normal Splicing and Is Also Present in Normal Human Steroidogenic Tissues","volume":"84","author":"Saraco","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2016.05.025","article-title":"Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization","volume":"433","author":"Zhu","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4274\/jcrpe.2761","article-title":"A Novel Null Mutation in P450 Aromatase Gene (CYP19A1) Associated with Development of Hypoplastic Ovaries in Humans","volume":"8","author":"Kim","year":"2016","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_178","first-page":"275","article-title":"Aromatase Deficiency due to a Homozygous CYP19A1 Mutation in a 46,XX Egyptian Patient with Ambiguous Genitalia","volume":"11","author":"Mazen","year":"2017","journal-title":"Sex. Dev. Genet. Mol. Biol. Evol. Endocrinol. Embryol. Pathol. Sex Determ. Differ."},{"key":"ref_179","first-page":"377","article-title":"Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene","volume":"10","author":"Unal","year":"2018","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0032-1324798","article-title":"Aromatase deficiency: Rare cause of virilization","volume":"23","author":"Ludwikowski","year":"2013","journal-title":"Eur. J. Pediatr. Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1515\/jpem-2012-0152","article-title":"Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency","volume":"25","author":"Verma","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab. JPEM"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000341585","article-title":"Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency","volume":"78","author":"Janner","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1300","article-title":"Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome","volume":"36","author":"Tajima","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/429417","article-title":"Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis","volume":"76","author":"Huang","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","article-title":"Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study","volume":"363","author":"Arlt","year":"2004","journal-title":"Lancet Lond. Engl."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM198511073131903","article-title":"Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia","volume":"313","author":"Peterson","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1210\/jc.2010-1607","article-title":"Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"96","author":"Idkowiak","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1210\/jc.2011-0640","article-title":"Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"97","author":"Krone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jc.2004-0810","article-title":"Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and\/or impaired steroidogenesis: molecular and clinical studies in 10 patients","volume":"90","author":"Fukami","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2005-2460","article-title":"Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone","volume":"91","author":"Homma","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1210\/jc.2006-2345","article-title":"Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency","volume":"92","author":"Scott","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2008-2816","article-title":"Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients","volume":"94","author":"Fukami","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1210\/jc.2009-1460","article-title":"Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients","volume":"94","author":"Sahakitrungruang","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.bbrc.2011.08.001","article-title":"Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency","volume":"412","author":"Mallet","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.30169","article-title":"Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome","volume":"128","author":"Adachi","year":"2004","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004310050048","article-title":"Features of Antley-Bixler syndrome in an infant born to a mother with pregnancy luteoma","volume":"159","author":"Roth","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.30170","article-title":"Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome","volume":"129","author":"Cragun","year":"2004","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajmg.a.30104","article-title":"Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis","volume":"128","author":"Shackleton","year":"2004","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ajmg.a.31385","article-title":"Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency","volume":"140A","author":"Williamson","year":"2006","journal-title":"Am. J. Med. Genet. A."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00431-008-0849-0","article-title":"A case of Antley-Bixler syndrome caused by compound heterozygous mutations of the cytochrome P450 oxidoreductase gene","volume":"168","author":"Ko","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"ref_201","first-page":"59","article-title":"Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency","volume":"16","author":"But","year":"2010","journal-title":"Hong Kong Med. J. Xianggang Yi Xue Za Zhi"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1590\/S0004-27302012000800020","article-title":"46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene","volume":"56","author":"Castro","year":"2012","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"882","DOI":"10.12659\/AJCR.895526","article-title":"Prenatal Diagnosis of Antley-Bixler Syndrome and POR Deficiency","volume":"16","author":"Oldani","year":"2015","journal-title":"Am. J. Case Rep."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2016.04.003","article-title":"P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms","volume":"165","author":"Burkhard","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3343\/alm.2017.37.6.559","article-title":"A Case of Antley-Bixler Syndrome With a Novel Likely Pathogenic Variant (c.529G>C) in the POR Gene","volume":"37","author":"Oh","year":"2017","journal-title":"Ann. Lab. Med."},{"key":"ref_206","first-page":"479","article-title":"A case of antley bixler syndrome: diagnosis and outcome","volume":"8","author":"Puiu","year":"2012","journal-title":"Acta Endocrinol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1203\/01.pdr.0000195825.31504.28","article-title":"Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and\/or aromatase deficiency: diagnostic value of urine steroid hormone analysis","volume":"59","author":"Fukami","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mce.2010.10.022","article-title":"Consequences of POR mutations and polymorphisms","volume":"336","author":"Miller","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/me.2007-0245","article-title":"Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase","volume":"21","author":"Pandey","year":"2007","journal-title":"Mol. Endocrinol. Baltim. Md"},{"key":"ref_210","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J., Stephens, K., and Amemiya, A. (2017, August 03). Cytochrome P450 Oxidoreductase Deficiency, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1419\/."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1210\/jc.2012-3449","article-title":"Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency","volume":"98","author":"Reisch","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2005-0096","article-title":"Minireview: regulation of steroidogenesis by electron transfer","volume":"146","author":"Miller","year":"2005","journal-title":"Endocrinology"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","article-title":"NADPH P450 oxidoreductase: structure, function, and pathology of diseases","volume":"138","author":"Pandey","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/FPC.0b013e328358d92b","article-title":"Pharmacogenetics of P450 oxidoreductase: Implications in drug metabolism and therapy","volume":"22","author":"Hu","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-10-0764","article-title":"Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency","volume":"163","author":"Maiter","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_216","first-page":"266","article-title":"Genetic and clinical features of p450 oxidoreductase deficiency","volume":"69","author":"Scott","year":"2008","journal-title":"Horm. Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajhg.2011.09.015","article-title":"Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid","volume":"89","author":"Laue","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(02)11203-7","article-title":"Clinical importance of the cytochromes P450","volume":"360","author":"Nebert","year":"2002","journal-title":"Lancet Lond. Engl."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4605\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:09Z","timestamp":1760188869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":218,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ijms20184605"],"URL":"https:\/\/doi.org\/10.3390\/ijms20184605","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,17]]}}}